Medicare will begin covering GLP-1 medications for obesity through the Medicare GLP-1 Bridge program starting July 1, 2026, offering eligible beneficiaries access for $50 per month
(It could be approved by late 2026.) Still, some guys like Johic are buying retatrutide at their own risk through a gray market of medical clinics and med spas, research peptide outlets (where drugs are sold for research purposes), compounding pharmacies, and e-commerce sites
Step 2: choose your primary site For most people, the site with the most subcutaneous tissue and easiest self-access becomes the primary site
Firstly, different body areas have varying amounts of subcutaneous fat, which can affect comfort during injection
And for others, it can help them taper off a GLP-1 while reducing their risk of rebound weight gain especially if they pair it with other lifestyle changes like regular physical activity and a nutritious diet
5 As we continue to understand the full spectrum of GLP-1s impact, these findings underscore its potential as a powerful tool in both metabolic and inflammatory health